dr yongsheng wang, general manager, jinyu biopharmaceuticals

21
致力健康事业 共创美好生活 Market Growth and Drivers in China Animal Health Dr. Yongsheng Wang Vice President of Jinyu Bio-Technology Co. Ltd. General Manager of Jinyu Baoling Bio-pharma Co. Ltd

Upload: kisaco-research

Post on 13-Apr-2017

76 views

Category:

Business


0 download

TRANSCRIPT

致力健康事业 共创美好生活

Market Growth and Drivers in China Animal Health

Dr Yongsheng Wang Vice President of Jinyu Bio-Technology Co Ltd

General Manager of Jinyu Baoling Bio-pharma Co Ltd

Forward-Looking Statement bull These statements are based upon the current beliefs and expectations of Jinyursquos

management and are subject to significant risks and uncertainties If underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forward-looking statements

bull Risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of industry regulation and animal health legislation in China trends of animal health product cost technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval Jinyursquos ability to accurately predict future market conditions manufacturing difficulties or delays dependence on the effectiveness of Jinyursquos patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions

bull Jinyu undertakes no obligation to publicly update any forward-looking statement whether as a result of new information future events or otherwise Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Jinyursquos 2015 Annual Report and the companyrsquos other filings with the Shanghai Stock Exchange (SSE) available at the SSErsquos Internet site (wwwssecomcn)

Personal Experiences bull Vice President of Jinyu Bio-Technology Co Ltd General

Manager of Jinyu Baoling Bio-pharma Co Ltd since May 2014 bull Vice President of MSD (Merck) China and General Manager of

MSD Animal Health China during Jan 2013 to April 2014 bull Worked in Pfizer Animal Health (Zoetis) in different roles as

Director of Public Affairs in APAC General Manager National Sales Manager Regulatory Affairs Manager amp National Technical Service Manager in China during 1997-2012

bull Got PhD degree from China Agricultural University major in Bio-technology of animal reproduction and also had master and bachelor degree in veterinary medicine

Outline

bull Animal Health Market in China

bull Growth amp Key Drivers in China Animal Health

bull Briefing of Jinyu Bio-Technology Co Ltd

Animal Husbandry Industry

Pork 65

Chicken 25

BeefMutton 10

Meat Consumption

bull Animal husbandry is one of major agro-industry bull High output value290 Billion RMB bull 283 of total agro-industry output bull Swine production value account 18 of Agro-industry

Output of main animal products (10000 MT)

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Forward-Looking Statement bull These statements are based upon the current beliefs and expectations of Jinyursquos

management and are subject to significant risks and uncertainties If underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forward-looking statements

bull Risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of industry regulation and animal health legislation in China trends of animal health product cost technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval Jinyursquos ability to accurately predict future market conditions manufacturing difficulties or delays dependence on the effectiveness of Jinyursquos patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions

bull Jinyu undertakes no obligation to publicly update any forward-looking statement whether as a result of new information future events or otherwise Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Jinyursquos 2015 Annual Report and the companyrsquos other filings with the Shanghai Stock Exchange (SSE) available at the SSErsquos Internet site (wwwssecomcn)

Personal Experiences bull Vice President of Jinyu Bio-Technology Co Ltd General

Manager of Jinyu Baoling Bio-pharma Co Ltd since May 2014 bull Vice President of MSD (Merck) China and General Manager of

MSD Animal Health China during Jan 2013 to April 2014 bull Worked in Pfizer Animal Health (Zoetis) in different roles as

Director of Public Affairs in APAC General Manager National Sales Manager Regulatory Affairs Manager amp National Technical Service Manager in China during 1997-2012

bull Got PhD degree from China Agricultural University major in Bio-technology of animal reproduction and also had master and bachelor degree in veterinary medicine

Outline

bull Animal Health Market in China

bull Growth amp Key Drivers in China Animal Health

bull Briefing of Jinyu Bio-Technology Co Ltd

Animal Husbandry Industry

Pork 65

Chicken 25

BeefMutton 10

Meat Consumption

bull Animal husbandry is one of major agro-industry bull High output value290 Billion RMB bull 283 of total agro-industry output bull Swine production value account 18 of Agro-industry

Output of main animal products (10000 MT)

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Personal Experiences bull Vice President of Jinyu Bio-Technology Co Ltd General

Manager of Jinyu Baoling Bio-pharma Co Ltd since May 2014 bull Vice President of MSD (Merck) China and General Manager of

MSD Animal Health China during Jan 2013 to April 2014 bull Worked in Pfizer Animal Health (Zoetis) in different roles as

Director of Public Affairs in APAC General Manager National Sales Manager Regulatory Affairs Manager amp National Technical Service Manager in China during 1997-2012

bull Got PhD degree from China Agricultural University major in Bio-technology of animal reproduction and also had master and bachelor degree in veterinary medicine

Outline

bull Animal Health Market in China

bull Growth amp Key Drivers in China Animal Health

bull Briefing of Jinyu Bio-Technology Co Ltd

Animal Husbandry Industry

Pork 65

Chicken 25

BeefMutton 10

Meat Consumption

bull Animal husbandry is one of major agro-industry bull High output value290 Billion RMB bull 283 of total agro-industry output bull Swine production value account 18 of Agro-industry

Output of main animal products (10000 MT)

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Outline

bull Animal Health Market in China

bull Growth amp Key Drivers in China Animal Health

bull Briefing of Jinyu Bio-Technology Co Ltd

Animal Husbandry Industry

Pork 65

Chicken 25

BeefMutton 10

Meat Consumption

bull Animal husbandry is one of major agro-industry bull High output value290 Billion RMB bull 283 of total agro-industry output bull Swine production value account 18 of Agro-industry

Output of main animal products (10000 MT)

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Animal Husbandry Industry

Pork 65

Chicken 25

BeefMutton 10

Meat Consumption

bull Animal husbandry is one of major agro-industry bull High output value290 Billion RMB bull 283 of total agro-industry output bull Swine production value account 18 of Agro-industry

Output of main animal products (10000 MT)

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Chart1

Meat Consumption
065
025
01

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角
Pork
Chicken
BeefMutton

Sheet1

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Meat Consumption
Pork 65
Chicken 25
BeefMutton 10
若要调整图表数据区域的大小请拖拽区域的右下角

Chart1

Pork
Beef
Mutton
Egg
Milk
455533
5681
35006
243812
275337
465045
57667
36384
2424
319341
428782
61341
38262
252898
352524
46205
61317
38035
27022
355582
489076
63554
38942
274247
351884
507124
65306
39886
276274
357562
50604
64749
3931
281142
365785
53427
66226
40099
286117
37436
549303
67321
40814
287606
353142
5671
689
428
2984
3725

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583
2005 2005 2005 2005 2005
2006 2006 2006 2006 2006
2007 2007 2007 2007 2007
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014

存栏

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Beef 10991 10465 10595 10576 10727 10626 10360 10343 10385
Mutton 29793 28370 28565 28085 28452 28088 28236 28504 29036
Pork 43319 41850 43989 46291 46996 46460 46863 47592 47411 46583

存栏

Beef
Mutton
Pork

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

出栏

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

畜产品产量

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pork 4555 4650 4288 4621 4891 5071 5060 5343 5493 5671
Beef 568 577 613 613 636 653 647 662 673 689
Mutton 350 364 383 380 389 399 393 401 408 428
Egg 2438 2424 2529 2702 2742 2763 2811 2861 2876 2984
Milk 2753 3193 3525 3556 3519 3576 3658 3744 3531 3725

畜产品产量

Pork
Beef
Mutton
Egg
Milk

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014

Livestock Industry bull Swine

bull Output 7351 million in 2014 27G bull Inventory of sow 4289 million -147G bull Market 1374 pigs per sow per year

bull Cattle bull Inventory 10385 million - 016G

bull Inner Mongolian6250 million -014G bull Dairy

bull Inventory 1420 million -014G bull Inner Mongolian335 million236 of

nation total bull SheepGoat

bull Inventory 28504million 095G bull Inner Mongoliany5144 million 18 of

total bull Sheep Inventory 14367 million29G

bull Inner Mongolian3484 million243 of total

bull Goat inventory 14136 million - 097G bull Inner Mongolian1660 million 117 of

total

Inventory of livestock ( 10000)

Cattle Sheepgoat Pig

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014

Poultry Industry

bull Broiler bull Output 855 MM

-8G bull White-8G bull Yellow-11G

Layer Inventory 1445 MM-1G Grandparent breeding 5124

thousand 6 big farms Parent breeding178 MM No 1 egg production in the

world since 1985

Million

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014

Animal Health Industry bull 2014 total market is 407

billion RMB Bios 104 billion RMB

bull CAGR is 1084 from 2007

to 2014

bull There are 1809 companies for animal health 82 for vaccine

bull Swine amp poultry vaccine dominated vaccine market bull Swine 488 billion RMB account

47 bull Poultry 367 billion RMB

account 354

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014

Chart1

Pharma
Bios
Pharma Growth
Bios Growth
152
46
02774
01
184
55
02105263158
01956521739
206
60
01195652174
00909090909
239
66
01601941748
01
265
73
01087866109
01060606061
308
82
01622641509
01232876712
308
94
0
01463414634
303
104
-00162337662
01063829787

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2007 2007 2007 2007
2008 2008 2008 2008
2009 2009 2009 2009
2010 2010 2010 2010
2011 2011 2011 2011
2012 2012 2012 2012
2013 2013 2013 2013
2014 2014 2014 2014

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other

Sheet3

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other

Chart1

04699
03535
01459
00054
00253

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Pig
Poultry
Ruminant
Rabbit
Other

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry

Animal Health Industry bull Mandatory Vaccine 556 billion RMB

bull FMD AI bull PRRS amp CSF will exit the list from (2017 bull Brucellosis amp Peste des petits ruminants virus (PPRV) will be

added bull Swine vaccine dominated

Mandatory Common Pig

Poultry

Ruminant

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry

Chart1

482
349
118
089

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Non-Mandatory
Pig
Ruminant
Poultry

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014

Animal Health Industry bull Innovation

bull 2014 investment in RampD is 273 billion 67 of total revenue

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014

Chart1

1st
2nd
3rd
4th
5th
1
14
17
1
0
2
8
24
3
0
3
17
29
4
0
1
16
25
8
2
3
5
27
6
1
1
14
27
6
1
1
12
28
3
34

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
2008 2008 2008 2008 2008
2009 2009 2009 2009 2009
2010 2010 2010 2010 2010
2011 2011 2011 2011 2011
2012 2012 2012 2012 2012
2013 2013 2013 2013 2013
2014 2014 2014 2014 2014

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

1st
2nd
3rd
4th
5th

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other

35

52

70

28

40

55

68 73

80

0102030405060708090

2010 2015E 2020E

bull Output increase of livestock amp poultry bull MOA issue 2016-2020 development plan for swine and ruminant

industry bull Productive efficiency improve

bull market 19 pigs per sow per year by 2020 bull Ratio of commercial farms increase

Pig Layer Broiler

Growth amp Key Drivers

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other

Growth amp Key Drivers bull Animal health market will growth more than 10

annually bull Need high quality animal health products especially

vaccines bull Vaccines for private market will replace vaccines for

tender market and drive the growth

101112131415161718

0

5

10

15

20

25

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Cost of Swine Vaccines per Pig

Small farm Commercial far Commercial Farm G Small farm G

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other

Growth amp Key Drivers bull Companion animal

market quick growth bull Number of CA growth bull Expenses for CA increment

bull More specific care required (arthritis obesity diabetes) 150 million dog Annual Expense

Market size Growth

100 million

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other

Chart1

00766
00908
01062
00522
0104
00959
04743

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
Beijing
Shanghai
Guangdong
Shangdong
Jiangsu
Zhejiang
Other

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743

Sheet6

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743

Sheet6

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000

Chart1

009
032
019
029
011

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464
lt1000
1000-3000
3000-5000
5000-10000
gt10000

Sheet1

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106
Pork Beef Mutton Milk
2005年 45553 5681 3501 27534
2006年 46505 5767 3638 319341
2007年 42878 6134 3826 352524
2008年 46205 6132 38035 35558
2009年 48908 63554 3894 35188
2010年 50712 65307 3989 35756
2011年 506043 64749 3931 365785
2012年 53427 66226 40099 37436
2013年 549303 67321 40814 353142
2014年 567139 68924 42821 372464

Sheet2

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253
Pharma Bios Pharma Growth Bios Growth
2007 152 46 277 100
2008 184 55 211 196
2009 206 60 120 91
2010 239 66 160 100
2011 265 73 109 106
2012 308 82 162 123
2013 308 94 00 146
2014 303 104 -16 106

Sheet2

Pharma
Bios
Pharma Growth
Bios Growth

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089
Pig 4699
Poultry 3535
Ruminant 1459
Rabbit 054
Other 253

Sheet3

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34
Mandatory 556
Non-Mandatory 482
Pig 349
Ruminant 118
Poultry 089

Sheet4

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743
1st 2nd 3rd 4th 5th
2008 1 14 17 1 0
2009 2 8 24 3 0
2010 3 17 29 4 0
2011 1 16 25 8 2
2012 3 5 27 6 1
2013 1 14 27 6 1
2014 1 12 28 3 34

Sheet5

1st
2nd
3rd
4th
5th

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743

Sheet6

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11
Beijing 766
Shanghai 908
Guangdong 1062
Shangdong 522
Jiangsu 1040
Zhejiang 959
Other 4743

Sheet6

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11

Sheet7

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future
lt1000 9
1000-3000 32
3000-5000 19
5000-10000 29
gt10000 11

Sheet7

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Growth amp Key Drivers

bull RampD investment increase bull Innovative products amp technologies

will replace classic ones

bull Merger and acquisition will speed up concentration ration

bull BI+Merial bull Jinhe (Pharmgate LLC) acquired

Prota Tek International Inc bull Ruipu Bio-technology acquired

Huana Bio-technology

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing bull Found in 1993 bull Headquartered Hohhot Inner Mongolia bull Listed at ShangHai Stock Exchange in 1998 (stock code

600201) bull Engaged in animal health industry (AH) since 1995

focused on bio-pharmaceutical by divesting real estate business in early of 2013

bull Market Value $285 billion by Oct 15 2016 bull Employees 990 bull Two manufacturing sites

bull Jinyu Baoling bull Yangzhou Youbang

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing

Core Advantages

RampD Advantages bull National Engineering Lab of Animal Vaccine bull National Engineering Lab of Animal Vaccine bull National High-Level Biosafety Lab bull First launch trivalent inactivated

vaccine of FMD (O Asia I amp A)for cattle and genetic engineering vaccine of FMD (O) for swine

First Mover Advantages bull First break down the technical barrier of using bioreactor for animal vaccine production in China bull Leading vaccine company for cattle sheepgoat and pig bull First one to promote FMD vaccine directly to farmers

Quality Advantages bull High content of FMD antigen bull Content of non-antigen protein and endotoxin in FMD vaccine decrease 90 compare to classic ones bull Using 15 serum in producing FMD vaccine compare with rotating bottle culture bull no antibiotic residue

TechnologyProcess Advantafes bull Cell suspension culture bull concentration and purification bull Remove of non-antigen protein more than 98 bull 146S quantitative detection for FMD antigen bull PCR Mycoplasma Testing quick high specificity and sensitivity bullIdentify subtypes of FMD virus by specific FMD primers design

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing bull Marketing amp Sales

bull 4 specific sales team with 150 person (direct sales swine ruminant tender)

bull Excellent marketing network (channel) covering 31 provinces bull Dedicated technical service team with 29 staffs

bull Collaboration bull Since 2012start strategic and technologic exchanges with

famous pharmaceuticvaccine companies from France Switzerland Germany USA etc

bull Sign collaborative agreement with Ceva for brucellosis vaccine in 2013

bull Project with Ethiopia government bull Project with Gates Foundation

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing bull Market position

bull Leading animal vaccine company with market share 12 in China in 2015

bull No 1 FMD vaccine company in China bull Direct sales gt60 market share bull Government procurement tendering 23 market share

Revenue (10000 RMB) Growth

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing bull Biological Science amp Technology Industrial Park

bull Four functional areas Veterinary bio-pharmaceutics Human bio-pharmaceutics Sino-foreign joint venture of biochemical pharmaceutics RampD supporting and other comprehensive facilities

bull Cover total area of more than 500000 M2 bull 1st phase investment 25 billion RMB bull Construction period about 3 years

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

Jinyu Briefing

bull Dedicate to a healthier and better life Vision

bull Protecting animal safety ensuring human health Mission

bull Responsibility Innovation Value Value

bull Being a globalized leading company in bio-pharmaceutical industry by introducing new technology expanding portfolio and marketing

Strategic Objective

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future

致力健康事业 共创美好生活

Thank you Looking forward to cooperation in near future

Cell Phone+86 15847663222 Emailwangyongshengjinyubaolingcomcn

  • Market Growth and Drivers in China Animal Health
  • Forward-Looking Statement
  • Personal Experiences
  • Outline
  • Animal Husbandry Industry
  • Livestock Industry
  • Poultry Industry
  • Animal Health Industry
  • Animal Health Industry
  • Animal Health Industry
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Growth amp Key Drivers
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • Jinyu Briefing
  • 幻灯片编号 20
  • Thank youLooking forward to cooperation in near future